Remove Cosmetics Remove Production Remove Vaccination
article thumbnail

Juno Pharmaceuticals buys Omega Laboratories

Pharmaceutical Technology

It will benefit from Omega’s newly opened injectable manufacturing facility, which has received clearances from Health Canada and the US Food and Drug Administration, as well as from Juno’s commercial network and product development pipeline.

Cosmetics 130
article thumbnail

Biosimilars vs. Interchangeable Biological Products: FDA Fact Check

XTalks

While the approval pathway for biosimilar products was established 12 years ago, there are still misconceptions about how biosimilars are approved, biosimilarity versus interchangeable status and which patients can be treated with biosimilars. What is an Interchangeable Biological Product? What is a Biosimilar?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

FDA Alerts the Public to Potentially Contaminated Products from Family Dollar Stores in Six States

The Pharma Data

Food and Drug Administration is alerting the public that several categories of FDA-regulated products purchased from Jan. The FDA is working with the company to initiate a voluntary recall External Link Disclaimer of the affected products. Families rely on stores like Family Dollar for products such as food and medicine.

article thumbnail

FDA to Hold Advisory Committee Meeting on COVID-19 Vaccines to Discuss Future Boosters

The Pharma Data

Food and Drug Administration is announcing a virtual meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Wed., Timing and populations for COVID-19 vaccine booster doses in the coming months. Along with the independent experts of the advisory committee, representatives from the U.S.

Vaccine 52
article thumbnail

FDA Announces Tentative Advisory Committee Meeting Schedule Regarding COVID- 19 Vaccines

The Pharma Data

Food and Drug Administration is announcing its plans to hold virtual meetings of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) in anticipation of complete submissions of emergency use authorization (EUA) requests in the coming months that have been publicly announced by COVID-19 vaccine manufacturers.

Vaccine 52
article thumbnail

FDA Announces Advisory Committee Meeting to Discuss COVID-19 Vaccine Candidate

The Pharma Data

Food and Drug Administration has scheduled a meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Dec. 10 to discuss the request for emergency use authorization (EUA) of a COVID-19 vaccine from Pfizer, Inc. BNT162b2 (SARS-CoV-2 vaccine) FDA Approval History. Source: FDA.

Vaccine 52
article thumbnail

FDA Limits Use of Janssen COVID-19 Vaccine to Certain Individuals

The Pharma Data

The Fact Sheet for Healthcare Providers Administering Vaccine now reflects the revision of the authorized use of the Janssen COVID-19 Vaccine and includes a warning statement at the beginning of the fact sheet for prominence which summarizes information on the risk for TTS.

Vaccine 52